Model Predicts Survival Time In Patients With Recurrent Renal Cell Carcinoma
Mon, 09 Oct 2006 07:00 AM EST
... In the July 1, 2006 issue of the Journal of Clinical Oncology, Dr. Eggener and associates at Memorial Sloan Kettering Cancer Center describe a model that stratifies patients with a recurrence of renal cell carcinoma (RCCA) by risk factors to predict survival time. The authors applied the criteria previously described by Dr. Robert Motzer for patients with metastatic RCCA. [click link for full article] ...
Related Topics
- Skin Cancer
- Small Cell Lung Cancer
- Renal Cell Cancer
- Kidney Cancer
- Renal cell carcinoma
- Disease models
- Kidney (Renal Cell) Cancer
- Renal Cell (Kidney) Cancer
- Merkel Cell Carcinoma
- Islet Cell Carcinoma
- Non-Hodgkin's Lymphoma
- Squamous cell carcinoma
- Hodgkin's Lymphoma
- Islet Cell Carcinoma (Pancreatic)
- Skin Carcinoma, Merkel Cell
- Basal Cell Carcinoma, see Skin Cancer
- Islet Cell Carcinoma (Endocrine Pancreas)
- Squamous Cell Carcinoma, see Skin Cancer
- Lung Cancer
- Sickle Cell Anemia

Not Signed In -

